Epitopea ApS
Private limited companyCVR 45664872KlampenborgActive
Epitopea ApS is a private limited company, based in Klampenborg, active in research and experimental development on natural sciences and engineering, founded in 2025. Equity was negative at the end of 2026 (−DKK 8.7m). The company is new and has been registered for 1 years. The latest net result (2026) was a loss of DKK 8.7m.
Key figures · financial year 2026
What has changed
calculated from recorded figures and datesManagement and owners, last 24 months
- New in management: Klaus Edvardsen (director, 05/06/2025).
- New owners registered: Epitopea Limited (05/06/2025).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2026–2026 · amounts in DKK thousand| 2026 | Change | |
|---|---|---|
| Revenue | not stated | – |
| Gross profit | −1,437 | – |
| Operating profit (EBIT) | −8,491 | – |
| Profit before tax | −8,708 | – |
| Net profit | −8,708 | – |
| Total assets | 2,704 | – |
| Equity | −8,688 | – |
| Liabilities | 11,393 | – |
| Cash and cash equivalents | 2,572 | – |
| Average number of employees | 0 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2026: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2026 figuresNegative equity
Equity was −DKK 8.7m at the end of 2026.
How is this calculated?
Equity in the latest annual report is below zero.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
1 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2026 | 05/06/2025 – 30/04/2026 | 09/09/2026 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,002of 69,742 Better than 1% | No. 69,531of 69,964 Better than 1% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 261of 323 Better than 19% | No. 306of 329 Better than 7% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,363of 16,614 Better than 2% | No. 16,578of 16,661 Better than 0% |
| All companies of type ApS66,508 companies in the comparison | No. 65,789of 66,379 Better than 1% | No. 66,069of 66,505 Better than 1% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Epitopea ApS−DKK 1.4m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Epitopea ApS−DKK 8.7m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Epitopea ApS−DKK 8.7m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Epitopea ApS3
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Epitopea Limited100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Klaus Edvardsen | Director | 05/06/2025 |
- Founders
- Epitopea Limited
Signing rule: Selskabet tegnes af 1 direktør
Address and production units
1 active production unitsKlampenborgvej 26
2930 Klampenborg
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Epitopea ApS | Klampenborgvej 26, 2930 Klampenborg | 3 | 1031401158 |
Purpose
Selskabets formål er at drive virksomhed med klinisk udvikling af farmaceutiske terapier mod kræft samt anden virksomhed, der står i forbindelse hermed.
The purpose is quoted from the register in Danish.
Changes year by year
4 registered events20261 changeaccounts 1
- AccountsAnnual report for 2026 published
20253 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as Epitopea ApS
- ManagementKlaus Edvardsen appointed director
- OwnershipEpitopea Limited registered as owner (100%)
Related companies
Same industry in Gentofte
- Pharmaceutical Research Associates Denmark ApS50 employees
- Novo Nordisk Clinical Innovation Centre A/S32 employees
- Bioporto Diagnostics A/S28 employees
- NIVI Development A/S9 employees
- Bioporto A/S8 employees
- Protein Frontiers ApS4 employees
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.